Anti-diarrheal drug loperamide induces dysbiosis in zebrafish microbiota via bacterial inhibition - Zebrafish Neurogenetics Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2023

Anti-diarrheal drug loperamide induces dysbiosis in zebrafish microbiota via bacterial inhibition

Résumé

Abstract Background: Perturbations of animal-associated microbiomes from chemical stress can affect host physiology and health. While dysbiosis induced by antibiotic treatments and disease are well known, chemical, non-antibiotic drugs have recently been shown to induce changes in microbiome composition, warranting further exploration. Loperamide is an opioid-receptor agonist drug widely prescribed drug for treating acute diarrhea in humans. Loperamide is also used as a tool to study the impact of bowel dysfunction in animal models by inducing constipation, but its effect on host-associated microbiota is poorly characterized. Results We used conventional and gnotobiotic larval zebrafish models to show that in addition to host-specific effects, loperamide also has anti-bacterial activities that directly induce changes in microbiota diversity. This dysbiosis is due to changes in bacterial colonization, since germ-free zebrafish mono-reconventionalized with bacterial strains sensitive to loperamide are colonized up to 100-fold lower when treated with loperamide. Consistently, the bacterial diversity of gnotobiotic zebrafish colonized by a mix of representative bacterial strains is affected by loperamide treatment. Conclusion Our results demonstrate that loperamide, in addition to host effects, also induces dysbiosis in a vertebrate model, highlighting that established treatments can have underlooked secondary effects on microbiota structure and function. This study further provides a insights for future studies exploring how common medications directly induce changes in host-associated microbiota. Graphical Abstract
Fichier principal
Vignette du fichier
2023.04.18.537295v1.full.pdf (1.6 Mo) Télécharger le fichier
licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification

Dates et versions

pasteur-04253857 , version 1 (23-10-2023)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Rebecca Stevick, Sébastien Bedu, Nicolas Dray, Jean-Marc Ghigo, David Pérez-Pascual. Anti-diarrheal drug loperamide induces dysbiosis in zebrafish microbiota via bacterial inhibition. 2023. ⟨pasteur-04253857⟩
11 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More